Texas AG investigating push to prescribe experimental puberty blockers not approved by FDA for kids

The Texas Attorney General’s office is investigating two pharmaceutical companies for their promotion of well-established drugs as puberty blockers despite the fact that they have not received approval from the Food and Drug Administration.

The Office of Texas’ Republican Attorney General Ken Paxton announced Monday that it was investigating Endo Pharmaceuticals and AbbVie Inc. under the Texas Deceptive Trade Practices Act.

“These pharmaceutical companies allegedly advertised and promoted hormone (puberty) blockers for unapproved uses without disclosing the potential risks associated with these drugs to children and their parents,” Paxton said in a statement.

“Medications Supprelin LA and Lupron Depot are approved to treat children with Central Precocious Property (CPP), when the puberty process begins prematurely. And Vantas, along with other forms of Lupron, has been prescribed for palliative treatment of prostate cancer. These drugs are now being used to treat gender dysphoria even though they are not approved for such use by the Food and Drug Administration (FDA).”.. (Excerpts from the Christian Post)